Showing results (21-30 of 61) with videos related to
Sort By:
Pageof 7
Journal of Immunology (Baltimore, Md. : 1950)|March 14, 2014
Differential role of Th1 and Th2 cytokines in autotoxicity driven by CD19-specific second-generation chimeric antigen receptor T cells in a mouse modelEleanor J Cheadle, Victoria Sheard, Dominic G Rothwell, et al.The Journal of Experimental Medicine|April 3, 2019
Single-cell imaging of CAR T cell activity in vivo reveals extensive functional and anatomical heterogeneityMarine Cazaux, Capucine L Grandjean, Fabrice Lemaître, et al.Methods in Molecular Biology (Clifton, N.J.)|August 22, 2012
Chimeric antigen receptors for T-cell based therapyEleanor J Cheadle, Vicky Sheard, Andreas A Hombach, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 15, 2017
Preclinical Assessment of CAR T-Cell Therapy Targeting the Tumor Antigen 5T4 in Ovarian CancerGemma L Owens, Victoria E Sheard, Milena Kalaitsidou, et al.Frontiers in Cell and Developmental Biology|November 29, 2023
Stromal cell inhibition of anti-CD20 antibody mediated killing of B-cell malignanciesEster Fagnano, Swati Pendharkar, Madyson Colton, et al.Oncology Research|March 9, 2026
Investigating the Immune Effects of Radiotherapy in Non-Small Cell Lung Cancer-Results of the PD-RAD StudyShuhui Cheng, Tiana Kordbacheh, Antonia Banyard, et al.Immunotherapy|July 20, 2010
Recent advances in bacillus Calmette-Guerin immunotherapy in bladder cancerAnton B Alexandroff, Steve Nicholson, Poulam M Patel, et al.Communications Medicine|April 1, 2026
Longitudinal plasma nano-proteomics reveals acute systemic responses to radiotherapy and predictive biomarkers of late toxicityHanan Abumanhal-Masarweh, Salam A Assi, Xinming Liu, et al.International Journal of Cancer|May 27, 2003
Recombinant E. coli efficiently delivers antigen and maturation signals to human dendritic cells: presentation of MART1 to CD8+ T cellsKristen J Radford, Andrew M Jackson, Jui-Ho Wang, et al.Cancer Immunology, Immunotherapy : CII|November 6, 2013
Definition and application of good manufacturing process-compliant production of CEA-specific chimeric antigen receptor expressing T-cells for phase I/II clinical trialRyan D Guest, Natalia Kirillova, Sam Mowbray, et al.Pageof 7